Scientists create engineered T cells to control overactive immune responses, aiding transplants and autoimmune diseases.

Scientists at UC San Francisco have developed engineered T cells that act as "referees" to control overactive immune responses, potentially reducing the need for immunosuppressant drugs. This technology can protect transplanted organs and treat autoimmune conditions like type 1 diabetes by calming the immune system in a targeted manner. The modified cells could also enhance CAR T cell therapies for cancer with fewer side effects.

4 months ago
4 Articles

Further Reading